Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCP2 | P22307 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.57 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7812704 | 0.97 | SCP2 (0.93) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL3501312 | 0.90 | SCP2 (0.82) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL7815701 | 0.88 | SCP2 (0.79) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL7812016 | 0.88 | SCP2 (0.78) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL62370 | 0.87 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL4662862 | 0.87 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL19646592 | 0.87 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL26434823 | 0.86 | SCP2 (0.76) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL13201656 | 0.86 | SCP2 (0.76) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL26434988 | 0.86 | SCP2 (0.75) | SCP2MEN1NPC1POLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080038840-A1 | Fluorescent Method And Compounds To Monitor Protein-Lipid Binding | EUROPAEISCHES LABORATORIUM FUER MOLEKULARBIOLOGIE (DE) | 2008-02-14 | — | — | US | disclosed |
| US-20080038840-A1 | Fluorescent Method And Compounds To Monitor Protein-Lipid Binding | EUROPAEISCHES LABORATORIUM FUER MOLEKULARBIOLOGIE (DE) | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080038840-A1 | Fluorescent Method And Compounds To Monitor Protein-Lipid Binding | DBI, CETP, SREBF1 | SCP2 34/4885MEN1 3143/4885NPC1 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.